• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
ZHENG Jiamin,GUO Long,DING Hongyan,ZOU Liyi,LIU Yi.Research progress of ulva polysaccharide in cancer[J].Journal Of Pharmaceutical Research,2026,45(7):788-795[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 944times   Download 603次 QR Code for this article
Scan with your phone!
石莼多糖在肿瘤中的研究进展
郑嘉敏1,郭龙1,丁鸿燕1,邹丽宜2,刘义1
Font:Larger+|Default|Smaller-
(1.广东医科大学海洋与热带医学学院,广东 湛江 524023;2.广东医科大学药学院,广东 东莞 523808)
摘要:
石莼多糖是一种源自绿藻石莼的硫酸化多糖,具有结构复杂、生物相容性好和低毒性的特点。研究表明,石莼多糖通过多种分子机制发挥显著的抗肿瘤活性,且石莼多糖与现有化疗药物联用可产生协同增效作用,并有助于减轻化疗引起的毒副作用,显示出作为新型抗肿瘤佐剂或药物的潜力。未来的研究重点在于深入阐明其精确的作用机制,并推动规范化的临床转化,这为开发高效低毒的肿瘤治疗新策略提供了重要方向。
关键词:  石莼多糖  抗肿瘤活性  构效关系  多靶点作用  辅助治疗
DOI:10.13506/j.cnki.jpr.2026.07.011
基金项目:广东省协同创新与平台环境建设项目(No.2017A040404052);广东省级促进经济发展专项资金(海洋经济发展用途)项目(No.GDME-2018C011)
Received Date:January 08, 2026   Revision Date:April 16, 2026   Publication Date:July 31, 2026
Research progress of ulva polysaccharide in cancer
ZHENG Jiamin1,GUO Long1,DING Hongyan1,ZOU Liyi2,LIU Yi1
(1. School of Ocean and Tropical Medicine, Guangdong Medical University, Zhanjiang 524023, China; 2. School of Pharmacy, Guangdong Medical University, Dongguan 523808, China)
Abstract:
Ulva polysaccharide, a sulfated polysaccharide derived from the green alga Ulva, is characterized by its structural complexity, good biocompatibility, and low toxicity. Research has demonstrated its significant anti-tumor activity through various molecular mechanisms. Notably, Ulva polysaccharide exhibits synergistic effects when combined with conventional chemotherapeutic agents and can help alleviate their associated side effects, highlighting its potential as a novel anti-tumor adjuvant or therapeutic agent. Future research should focus on elucidating its precise mechanisms of action and promoting standardized clinical translation, which offers important direction for developing new, efficient, and low-toxicity strategies for cancer therapy.
Key words:  Ulva polysaccharide, Antitumor activity, Structure-activity relationship, Multi-target mechanism, Adjunctive therapy
Today's Visits:447    Total Visits:2383131
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.